Anemia of cancer (Q40945074)

25 September 2017

1 reference

title

Anemia of cancer (English)

1 reference

25 September 2017

Moliterno AR

1 reference

25 September 2017

Spivak JL

series ordinal

1 reference

25 September 2017

publication date

1 April 1996

1 reference

Hematology / Oncology Clinics of North America

25 September 2017

published in

1 reference

25 September 2017

1 reference

25 September 2017

1 reference

25 September 2017

page(s)

345-363

1 reference

Recombinant human erythropoietin and the anemia of multiple myeloma

25 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970342-7

7 January 2021

Studies on the role of recombinant human erythropoietin in the growth regulation of human nonhematopoietic tumor cells in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970342-7

7 January 2021

Blood transfusions and prognosis in colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970342-7

7 January 2021

The significance of anemia in clinical radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970342-7

7 January 2021

Carcinoma-associated hemolytic-uremic syndrome: a complication of mitomycin C chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970342-7

7 January 2021

Erythropoiesis in the Anaemia of Chronic Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970342-7

7 January 2021

Recombinant human erythropoietin treatment in cisplatin-associated anemia: a randomized, double-blind trial with placebo

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970342-7

7 January 2021

Relation of serum erythropoietin levels to renal excretory function: evidence for lowered set point for erythropoietin production in chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970342-7

7 January 2021

Reduced erythropoietin levels as a cause of anaemia in patients with lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970342-7

7 January 2021

Mechanisms of abnormal erythropoiesis in malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970342-7

7 January 2021

Development of radioimmunoassays for human erythropoietin using recombinant erythropoietin as tracer and immunogen.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970342-7

7 January 2021

Erythropoietin for the prevention of anaemia in neoplastic patients treated with cisplatin

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970342-7

7 January 2021

Cisplatin-induced hemolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970342-7

7 January 2021

Clinical application of recombinant erythropoietin in anemic cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970342-7

7 January 2021

Treatment of advanced non-small cell lung cancer with cisplatin, 5-fluorouracil, and mitomycin C

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970342-7

7 January 2021

Serum immunoreactive erythropoietin in rheumatoid arthritis: impaired response to anemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970342-7

7 January 2021

Thrombotic Microangiopathy and Renal Failure Associated with Antineoplastic Chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970342-7

7 January 2021

Recombinant human erythropoietin in patients with ovarian carcinoma and anaemia secondary to cisplatin and carboplatin chemotherapy: preliminary results

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970342-7

7 January 2021

Monokines inhibiting erythropoietin production in human hepatoma cultures and in isolated perfused rat kidneys

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970342-7

7 January 2021

Autoimmune disorders and malignant lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970342-7

7 January 2021

Erythropoietin retards DNA breakdown and prevents programmed death in erythroid progenitor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970342-7

7 January 2021

Cisplatin-induced anemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970342-7

7 January 2021

Erythropoietin increases hemoglobin in cancer patients during radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970342-7

7 January 2021

Quality of life in chronic anemia of cancer during treatment with recombinant human erythropoietin.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970342-7

7 January 2021

Microangiopathic hemolytic anemia in metastatic carcinoma. Report of eight cases

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970342-7

7 January 2021

Erythropoietin treatment of anemia associated with multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970342-7

7 January 2021

Inhibition of human erythroid colony-forming units by interleukin-1 is mediated by gamma interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970342-7

7 January 2021

Inhibition of human erythroid colony-forming units by tumor necrosis factor requires beta interferon.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970342-7

7 January 2021

Decreased erythropoietin response in patients with the anemia of cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970342-7

7 January 2021

Phase I-II Trial of Erythropoietin in the Treatment of Cisplatin-Associated Anemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970342-7

7 January 2021

Apoptosis of human erythroid colony‐forming cells is decreased by stem cell factor and insulin‐like growth factor I as well as erythropoietin

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970342-7

7 January 2021

A stochastic model of self-renewal and commitment to differentiation of the primitive hemopoietic stem cells in culture

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970342-7

7 January 2021

Prostate cancer recurrence in radical surgery patients receiving autologous or homologous blood

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970342-7

7 January 2021

Erythropoietin for the treatment of anemia of malignancy associated with neoplastic bone marrow infiltration

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970342-7

7 January 2021

Primary radiotherapy of larynx and pharynx carcinoma--an analysis of some factors influencing local control and survival

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970342-7

7 January 2021

Implications of the anemia of chronic disorders in patients anticipating radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970342-7

7 January 2021

Preliminary clinical experience withcis-diamminedichloroplatinum (II) (NSC 119875, CACP)

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970342-7

7 January 2021

Effect of cis-diamminedichloroplatinum on erythropoietin production and hematopoietic progenitor cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970342-7

7 January 2021

A syndrome of microangiopathic hemolytic anemia, renal impairment, and pulmonary edema in chemotherapy-treated patients with adenocarcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970342-7

7 January 2021

The frequency of red cell transfusion for anemia in patients receiving chemotherapy. A retrospective cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970342-7

7 January 2021

Autoimmune hemolytic anemia and carcinoma: An unusual association

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970342-7

7 January 2021

Serum immunoreactive erythropoietin in HIV-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970342-7

7 January 2021

Effect of subcutaneous recombinant human erythropoietin in cancer patients receiving radiotherapy: preliminary results of a randomized, open-labeled, phase II trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970342-7

7 January 2021

Cisplatin-associated anemia: an erythropoietin deficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970342-7

7 January 2021

Perioperative blood transfusions and cancer recurrence

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970342-7

7 January 2021

10.1016/S0889-8588(05)70342-7

Identifiers

DOI

1 reference

release_xuupy4v42revpabaoxtpfm2m4a

25 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/xuupy4v42revpabaoxtpfm2m4a

24 November 2022

mapped directly with Wikidata item

1 reference